Injection used by ‘unqualified nurse’ to treat late Mohbad has killed many —Report

0
189

The injection used by the ‘unqualified’ auxiliary nurse to treat the late Ilerioluwa Oladimeji Aloba popularly known as Mohbad has killed many people in the past, a report has revealed.

Recall that while giving preliminary report of an ongoing inquiry into the death of Mohbad, the Lagos Police Commissioner of Police, Idowu Owohunwa said that the nurse identified as Ms. Feyisayo Ogedengbe treated Mohbad with 1 Pack of Ceftriaxone injection; 1 Vial Paracetamol injection, Tetanus Toxoid injection, 1 Vial Procaine Penicillin, 7 ampules of IM Diclofenac, Tincture Iodine, and Needles/Syringes.

He said; “Ms Feyisayo administered the Tetanus Toxoid on the arm of MohBad and gave both the Paracetamol and Ceftriaxone injection intravenously; immediately the Ceftriaxone injection was administered, Ms. Feyisayo confirmed that MohBad started vomiting while goose bumps appeared on his face and all over the body.

However, a report published by the Nation newspaper has revealed that countries like Canada and the USA have banned the use of certain variants of Ceftriaxone in treating animals and chickens, citing ‘declines in the prevalence of cephalosporin-resistant Salmonella Heidelberg isolates in chicken meat and in humans’.

READ ALSO: Auxiliary nurse who treated Mohbad is principal suspect —Police (Video)  

Also, a 7-page publication by the Registration & Regulatory Affairs (R & R) Directorate of the National Agency for Food and Drug Administration and Control (NAFDAC), the use of ‘Ceftriaxone 1g powder for solution for injection/infusion’ emphatically asserts that “Consideration should be given to official guidelines on the appropriate use of antibacterial agents.”

Similarly, a review titled ‘Evaluation of the Clinical Use of Ceftriaxone among In-Patients in Selected Health Facilities in Uganda’, published on June 25, 2021, found that Ceftriaxone has a high propensity for misuse because of its high rate of utilization.

“In this study, we aimed at assessing the appropriateness of the clinical utilization of ceftriaxone in nine health facilities in Uganda; using the World Health Organization (WHO) Drug Use Evaluation indicators, we reviewed a systematic sample of 885 patients’ treatment records selected over a three (3)-month period.

“Ceftriaxone, like most cephalosporins, has a high prevalence of inappropriate prescriptions: Ceftriaxone has a high propensity for misuse because it is utilized in high quantities clinically and is prescribed uncontrolled in many countries including Uganda.

“Inappropriate use of antibiotics such as ceftriaxone accelerates the emergence of antimicrobial resistance, increases costs of treatment, affects productivity, and exposes patients to unnecessary side effects, and can also result in death,” it stated.

LEAVE A REPLY

Please enter your comment!
Please enter your name here